Loading…
Asensus Surgical has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG for KARL STORZ to acquire 100% of Asensus common stock for $0.35 per share in cash, representing a 66.7% premium. A bridge loan of up to $20 million has been provided.
“KARL STORZ has communicated that the proposed purchase price represents its 'best and final' offer to the Company.”business.newportvermontdailyexpress.com
Summarized from public sources; check the original articles before acting on it.